BioMarin Pharmaceutical Inc. (BMRN) News, Price and Chart

Sat March 27th, 2021

- 15:31
  EarningsAnalysisBioMarin (BMRN) Down 7.7% Since Last Earnings Report: Can It Rebound?Zacks

Mon March 15th, 2021

- 09:52
  AnalysisBioMarin: One Step Back Before The JumpSeeking Alpha

Mon March 8th, 2021

- 17:05
  BioMarin's Hemophilia Gene Therapy Scores RMAT Designation In USBenzinga

Wed March 3rd, 2021

- 13:31
  Press ReleasesBioMarin Completes Full Enrollment in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with AchondroplasiaPR Newswire

Sat February 27th, 2021

- 03:50
  Press ReleasesBIOMARIN INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BioMarin Pharmaceutical Inc. - BMRNPR Newswire

Fri February 26th, 2021

Wed February 24th, 2021

- 21:51
  AnalysisGeneration Bio: Pioneering A New Class Of Gene TherapySeeking Alpha

Sun February 21st, 2021

- 22:20
  IPOAnalysisThe Odds Of Winning The IPO LotterySeeking Alpha

Thu February 18th, 2021

- 21:01
  Press ReleasesBioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of DirectorsPR Newswire
- 17:33
  EarningsAnalysisEarnings Preview: BioMarin Pharmaceutical (BMRN) Q4 Earnings Expected to DeclineZacks

Fri February 12th, 2021

- 10:25
  AnalysisBioMarin Pharmaceutical (BMRN) Presents At J.P. Morgan 39th Annual Healthcare Conference - SlideshowSeeking Alpha

Thu February 4th, 2021

- 12:24
  AnalysisBioMarin's Hemophilia A Treatment: An AssessmentSeeking Alpha

Fri January 22nd, 2021

- 12:55
  AnalysisIs Now A Good Time To Buy BioMarin Stock?The Motley Fool

Mon January 11th, 2021

- 13:37
  AnalysisBioMarin (BMRN) Reveals 1-Year Data on Hemophilia Gene TherapyZacks

Sun January 10th, 2021

- 23:44
  Press ReleasesBioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and Secondary Efficacy Endpoints in One-Year Data SetPR Newswire

Tue December 22nd, 2020

- 01:06
  AnalysisUltragenyx: Upside But Not Without RiskSeeking Alpha

Fri December 18th, 2020

- 17:14
  Press ReleasesAnalysisThe Zacks Analyst Blog Highlights: BioMarin Pharmaceutical, uniQure, REGENXBIO and Deciphera PharmaceuticalsZacks

Sat December 5th, 2020

- 16:32
  EarningsAnalysisWhy Is BioMarin (BMRN) Up 6.1% Since Last Earnings Report?Zacks

Tue December 1st, 2020

- 21:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  IPOAnalysisIPO Update: Sigilon Therapeutics Aims For $101 Million IPOSeeking Alpha

Mon November 30th, 2020

- 17:12
  AnalysisPfizer: A 'New' Growth Foundation In Genomic MedicineSeeking Alpha

Tue November 24th, 2020

- 03:50
  Press ReleasesClass ActionsBIOMARIN 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRNPR Newswire

Thu November 19th, 2020

- 18:24
  IPOAnalysisSigilon Therapeutics Starts U.S. IPO PlanSeeking Alpha
- 04:18
  Press ReleasesClass ActionsROSEN, GLOBAL INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important November 24 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - BMRNPR Newswire

Tue November 17th, 2020

- 13:29
  Press ReleasesBioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial IntelligencePR Newswire

Mon November 16th, 2020

- 14:07
  AnalysisBioMarin: An Undervalued Leader With Multiple Catalysts In 2021Seeking Alpha

Sat November 7th, 2020

- 06:12
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisBioMarin Pharmaceutical Inc. (BMRN) CEO Jean-Jacques Bienaimé on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha
- 05:31
  EarningsAnalysisBiomarin Pharmaceutical Inc (BMRN) Q3 2020 Earnings Call TranscriptThe Motley Fool

Fri November 6th, 2020

- 15:57
  EarningsAnalysisBioMarin (BMRN) Beats on Q3 Earnings, Lowers Sales ViewZacks
- 11:02
  AnalysisHow BioMarin Beat Expectations in Q3The Motley Fool

Thu November 5th, 2020

- 22:35
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisBioMarin Pharmaceutical (BMRN) Q3 Earnings and Revenues Top EstimatesZacks
- 18:59
  AnalysisQuick Update On Bristol-Myers Squibb Contingent Value Rights After Dramatic Sell-OffSeeking Alpha

Tue November 3rd, 2020

- 01:55
  Press ReleasesFood and Drug Administration Accepts BioMarin's New Drug Application for Vosoritide to Treat Children with AchondroplasiaPR Newswire

Fri October 30th, 2020

- 23:44
  Press ReleasesClass ActionsROSEN, TRUSTED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important November 24 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - BMRNPR Newswire

Thu October 29th, 2020

- 16:35
  EarningsAnalysisAnalysts Estimate BioMarin Pharmaceutical (BMRN) to Report a Decline in Earnings: What to Look Out forZacks

Mon October 26th, 2020

- 21:50
  AnalysisBioMarin Pharmaceutical (BMRN) Stock Moves -0.84%: What You Should KnowZacks

Fri October 23rd, 2020

- 16:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisClearBridge Mid Cap Growth Strategy Portfolio Manager Commentary Q3 2020Seeking Alpha
- 16:00
  Press ReleasesClass ActionsGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioMarin Pharmaceuticals, Inc. (BMRN)PR Newswire
- 14:45
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisClearBridge All Cap Growth Strategy Portfolio Manager Commentary Q3 2020Seeking Alpha